MARKET

HBMHF

HBMHF

Hbm Hldgs
OTCPK
0.905
NaN%
Closed 09:30 03/18 EDT
OPEN
--
PREV CLOSE
0.905
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.905
52 WEEK LOW
0.905
MARKET CAP
685.13M
P/E (TTM)
31.30
1D
5D
1M
3M
1Y
5Y
1D
No Data
About HBMHF
Hbm Holdings Ltd is an investment holding company mainly engaged in the business of developing therapeutics in the fields of immuno-oncology and immunology diseases. The Company's products include HBM9161, HBM4003, HBM7008 and HBM1020. Batoclimab (HBM9161) is mainly used for immune thrombocytopenia (ITP), graves’ ophthalmopathy (GO), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD). Tanfanercept (HBM9036) is mainly used for dry eye disease (DED). The Company also researches and develops immuno-oncology portfolio, including internally developed next generation immune-oncology assets targeting immune-desert, immune-excluded and inflamed tumors. The Company owns Harbour Mice Platform, generating fully human monoclonal antibodies in the classical two heavy and two light chain H2L2 format as well as heavy chain only (HCAb) format.

Webull offers Hbm Holdings Ltd stock information, including OTCPK: HBMHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBMHF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBMHF stock methods without spending real money on the virtual paper trading platform.